ContractCollaborative Research and License Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction<DOCUMENT> <TYPE>EX-10.7 <SEQUENCE>16 <FILENAME>a2025040zex-10_7.txt <DESCRIPTION>EX 10.7 <TEXT> <PAGE> EXHIBIT 10.7 COLLABORATIVE RESEARCH AND LICENSE AGREEMENT THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT ("the Agreement") is entered into as of January 31, 1999 ("Effective Date") by and between PFIZER INC, a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017-5755 ("Pfizer") and RIGEL PHARMACEUTICALS, INC., a Delaware corporation, having an address at 772 Lucerne Drive, Sunnyvale, California 94086 ("Rigel"). Pfizer and Rigel and their Affiliates may be referred to herein individually as a "Party" or collectively as the "Parties." WHEREAS, Rigel has the capability and expertise to undertake research for the discovery of novel and selective elements of the IL-4 signaling pathway involved in the modulation of IgE synthesis that are suitable targets for an IgE synthesis-inhibitor, lead identification program; WHEREAS, Rigel owns the patents, pate